Bupropion sustained release treatment reduces fatigue in cancer patients.

Objective: To demonstrate that bupropion sustained release (SR) can reduce the symptoms of fatigue experienced by cancer patients.

Method: We studied an open-label case series of outpatients with fatigue referred for psychiatric assessment from a tertiary care cancer centre. Inclusion criteria were the presence of fatigue or depression with marked fatigue.